Latest HVIVO Press Release: Recommended Merger of hVIVO with Open Orphan

MENUMENU

Services
- - - Human challenge full-service solution
    - Industry leading provider of viral challenge studies
      
      See Our Solution
  - - hVIVO Challenge Models
  - - Laboratory Services
Investors
- - - Investors
      
      hVIVO’s shares are listed on the AIM market of the London Stock Exchange under the HVO ticker.
      
      This area is dedicated to keeping shareholders and potential investors informed.
News, Media & Events
- - - News, Media & Events
      
      A source for the latest press releases, scientific publications and other media as well as details of investor and scientific events that we attend and host across the world.
About Us
- - - About Us
      Our Mission is to build a profitable clinical development services business supporting product development for our clients through human challenge studies to establish early proof of concept.
      
      More about hVIVO
  - - LATEST PRESS RELEASE
      
      06.08.19 hVIVO Successfully Completes RSV Challenge Study in Older Adults
    - UPCOMING EVENTS
      
      World Vaccine Congress Europe 201929 Oct - 31 Oct, Barcelona, Spain, Palau de Congressos de Catalunya
Volunteers
Careers
Contact Us

Sitemap

Pages

Clinical Development Services
- Human challenge full-service solution
- hVIVO Challenge Models
- Laboratory Services
Cookies Policy
Home
hVIVO plc Interim Results for the 6 months ended 30 June 2019
hVIVO plc Interim Results for the 6-months ended 30 June 2018
hVIVO plc Preliminary Results for the 12-months ended 31 December 2018
Privacy policy
Scientific Papers / Abstracts
Search
Sitemap
Terms & Conditions
About Us
- Imutex Joint Venture
  - Imutex Ltd.
    - AGS – v
    - FLU – v
  - PrEP Biopharm Ltd
    - PrEP – 001
- Overview
- Board of Directors
- Quality Commitment
- Executive Leadership Team
- Ethics
Investors
- Advisers
- Aim Rule 26
- Analyst Coverage
- Audit Committee
- Financial Calendar
- Financial Reports
- Governance
- Presentations & Webcasts
- Recommended All-Equity Offer for hVIVO to merge with Open Orphan PLC
- Regulatory News
  - RNS Email Alerts – Subscribe for updates
- Remuneration Committee
- Share Price Info
- Shareholder Information
Volunteers
Careers
- Job Listings
News & Media
- Press Releases
- Videos
- News
- Events
- Press and Media Contact
- Scientific Papers / Abstracts
- Viroblog
Contact Us
Bronchial Allergen Challenge
Viral-Induced Asthma Exacerbation
Human Challenge Studies
Influenza Research
RSV Research
Lab Services
Target & Biomarker Discovery

Whether you’re a potential customer, job seeker, health professional or an investor, you can find the best way to contact us from the list below.

Contact Us

Terms & Conditions
Careers
Sitemap

© 2020 Copyright hVIVO Services Limited. All rights reserved. hVIVO Services Limited (“hVIVO”) is registered in England and Wales with registration number 02326557 and registered office at Queen Mary BioEnterprises Innovation Centre, 42 New Road, London, E1 2AX, UK.

Privacy Policy | Cookie Policy